Suspected Johnson & Johnson COVID-19 vaccine clot case reported in male, Utah hospital says
Fox News
A male patient younger than 50 is home recovering after being treated for what hospital officials suspect was a severe, rare clot event linked to the Johnson and Johnson COVID-19 vaccine.
The hospital said the patient responded to treatment and was released, and continues to be monitored closely. The hospital is waiting for confirmation from CDC on the case. "He is believed to be the third male in the U.S. to develop the rare condition," the news release stated.More Related News